Governor Rick Scott Appoints Dr. Michael Diaz to the Medicaid Pharmaceutical and Therapeutics Committee
Florida Cancer Specialists Pinellas County Physician
Florida – October 20th, 2017... On October 24, 2017, Governor Rick Scott announced four reappointments and six appointments to the Medicaid Pharmaceutical and Therapeutics Committee. Medical oncologist and hematologist for Florida Cancer Specialists in St. Petersburg, FL, Dr. Michael Diaz was one of the six appointed to the committee. Dr. Diaz succeeds Dr. Mark Hudak, and was appointed for a term beginning October 17, 2017, and ending June 30, 2019.
FCS CEO Brad Prechtl, said, “Dr. Michael Diaz is a great example of how many of our FCS leaders and employees go the extra mile to support not only our patients, but also serve on various committees. We are proud to announce that one of our physicians was appointed to the Medicaid Pharmaceutical and Therapeutics Committee.”
Dr. William Harwin, Founder and President of FCS, added, "Dr. Diaz is a highly respected medical onocolgist, and I know he will make a great addition to the Medicaid Pharmeutical and Therapeutics Committee.”
FCS Physician, Dr. Michael Diaz commented, “Previously, there was no oncology representation on the Medicaid Pharmaceutical and Therapeutics Committee. I am very grateful to have this opportunity to serve as a committee member, and hope to provide insight from the field of oncology and hematology.”
Dr. Michael Diaz joined Florida Cancer Specialists & Research Institute (FCS) in 2011 and currently serves on the FCS Executive Board and as Director of Patient Advocacy for the practice. Dr. Diaz also serves on the Board of Directors for the Florida Cancer Specialists Foundation, as Vice-Chair, which provides non-medical financial assistance to qualified cancer patients in Florida. In addition, he serves on the Board of Directors and as the Immediate Past President for the Florida Society of Clinical Oncology (FLASCO). Dr. Diaz also provides leadership on the Board of Directors for Community Oncology Alliance (COA) as Vice-President, serving on the Payment Reform Task Force working to champion Medical Oncology Health Care Reform and as a Co-Medical Director for the COA Patient Advocacy Network. He is active with the American Society of Clinical Oncology (ASCO) on multiple Work Groups and as a member of ASCO's Clinical Practice Committee. Dr. Diaz donates many hours as an active Medical Missionary and has participated in numerous medical missions to Kingston, Jamaica.
Florida Cancer Specialists & Research Institute offers a full range of oncology and hematology services, including clinical research and the use of evidence-based medicine and proactive patient support services. FCS is a strategic site of the Sarah Cannon Research Institute, one of the largest community-based clinical trial organizations in the United States.
About Florida Cancer Specialists & Research Institute: (FLCancer.com)
Founded in 1984, Florida Cancer Specialists & Research Institute (FCS) is the largest independent medical oncology/hematology practice in the United States. With over 200 physicians, 160 nurse practitioners and physician assistants and nearly 100 locations in our network, we are committed to providing world-class cancer care in community-based settings close to home.
Recognized by the American Society of Clinical Oncology (ASCO) with a national Clinical Trials Participation Award, FCS offers patients access to more clinical trials than any private oncology practice in Florida. 84% of new cancer drugs approved in 2016 for use in the U.S. were studied in clinical trials conducted with FCS participation.* Our physicians are consistently ranked nationally as Top Doctors by U.S. News & World Report Trained in such prestigious medical schools and research institutes as Duke, Stanford, Harvard, Emory, M.D. Anderson, and Memorial Sloan-Kettering, the physicians of Florida Cancer Specialists provide leadership and consultation in the state's leading hospitals.
FCS serves patients on the Gulf Coast from Naples to the greater Tampa Bay area, north as far as Tallahassee, in Orlando and surrounding Central Florida communities, and on the East Coast from Jacksonville/Fleming Island to Palm Beach County.
Florida Cancer Specialists has built a national reputation for excellence that is reflected in exceptional and compassionate patient care, driven by innovative clinical research and cutting-edge technologies that help advance targeted treatments and genetically-based immunotherapies, and embodied by our outstanding team of highly-trained and dedicated physicians, clinicians and staff.
*Prior to approval
For More Information, Contact:
Florida Cancer Specialists & Research Institute
Shelly Glenn, Chief Marketing & Sales Officer - SGlenn@FLCancer.com
Chris Wilkerson – firstname.lastname@example.org
Ganick Communications, Inc.
Elaine Ganick - email@example.com